XORTX Therapeutics (XRTX) Prepaid Assets (2020 - 2026)
XORTX Therapeutics (XRTX) posted Prepaid Assets of $56138.0 for Q1 2026, up 148.3% on a QoQ basis from $22609.0 in Q4 2025, and down 70.6% year-over-year from $190949.0 in Q1 2025.
XORTX Therapeutics (XRTX) Prepaid Assets (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $56138.0 for Q1 2026.
- Quarterly Prepaid Assets fell 70.6% year-over-year to $56138.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56138.0 (down 70.6% YoY) and the FY2025 annual result came in at $22609.0, down 87.81% from the prior year.
- Prepaid Assets was $56138.0 for Q1 2026 at XORTX Therapeutics, up from $22609.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $722716.6 in Q1 2022 and bottomed at $22609.0 in Q4 2025.
- A 5-year average of $219851.8 and a median of $185412.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 143.6% — and 2025, when it plunged 87.81%.
- XORTX Therapeutics' Prepaid Assets stood at $378783.2 in 2022, then slumped by 37.44% to $236966.0 in 2023, then dropped by 21.76% to $185412.0 in 2024, then plunged by 87.81% to $22609.0 in 2025, then soared by 148.3% to $56138.0 in 2026.
- Business Quant data shows XRTX's Prepaid Assets at $56138.0 in Q1 2026, $22609.0 in Q4 2025, and $30444.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,138.00 |
| Dec 31, 2025 | 22,609.00 |
| Sep 30, 2025 | 30,444.00 |
| Jun 30, 2025 | 97,589.00 |
| Mar 31, 2025 | 190,949.00 |
| Dec 31, 2024 | 185,412.00 |
| Sep 30, 2024 | 96,536.00 |
| Jun 30, 2024 | 207,290.00 |
| Mar 31, 2024 | 639,034.00 |
| Dec 31, 2023 | 236,966.00 |
| Sep 30, 2023 | 88,927.00 |
| Jun 30, 2023 | 183,667.00 |
| Mar 31, 2023 | 262,325.00 |
| Dec 31, 2022 | 378,783.18 |
| Sep 30, 2022 | 68,475.04 |
| Jun 30, 2022 | 269,619.45 |
| Mar 31, 2022 | 722,716.57 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 113,928.62 |
| Dec 31, 2020 | 202,655.08 |